新型手性抗肿瘤药物德氮吡格（TNBG）体外抗肿瘤活性初步研究

目的观察手性旋光异构体德氮吡格（TNBG）对6株人体肿瘤细胞增殖的影响,初步探讨其抗肿瘤作用机制。方法运用MTT法检测手性TNBG对6株肿瘤细胞生长抑制情况;油红O染色法观察QGY-7701细胞中脂质聚集情况;流式细胞仪检测手性TNBG对人肝癌细胞株QGY-7701细胞周期分布和凋亡影响。结果手性TNBG能不同程度抑制肿瘤细胞增殖,且呈剂量依赖性;油红O染色提取显示QGY-7701细胞内脂质量与给药剂量呈正相关;流式细胞仪检测到有s期细胞增加,并且手性TNBG还能诱导QGY-7701细胞发生凋亡。结论手性TNBG在体外具有良好的抗肿瘤活性,其抗肿瘤作用机制可能是通过促使肿瘤细胞产生脂质聚集,抑制肿瘤细胞增殖、诱导其凋亡从而达到抗肿瘤效应。总体看（＋）TNBG体外抗肿瘤活性比（-）TNBG更强。     

darbufelone对胃癌SGC-7901细胞裸鼠移植瘤血管生成的影响

目的观察环氧合酶-2／5-脂氧合酶双重抑制剂darbufelone对人胃癌皮下移植瘤血管生成的影响,并初步探讨其机制。方法建立裸鼠实体瘤模型,随机分为darbufelone组和对照组,darbufelone及生理盐水分别连续灌服4周。测量肿瘤质量、体积,计算抑瘤率;免疫组化检测CD34并计算微血管密度;RT—PCR法及Western blot法分析移植瘤组织中MMP-9、VEGF的表达。结果darbufelone可明显抑制裸鼠移植瘤的生长,质量抑瘤率为58．42％,体积抑瘤率为67．13％。darbufelone组的微血管密度（MVD）（15．36±0．30）明显低于对照组（29．47±0．63）（P〈0．05）;darbufelone组肿瘤组织中VEGF及MMP-9在基因水平及蛋白水平的表达（P〈0．05）。结论darbufelone能有效抑制裸鼠移植瘤的生长,减少移植瘤组织中VEGF及MMP-9的表达,抑制肿瘤的微血管生成,具有抗血管生成的作用。     

环磷酰胺抑瘤作用及含药血清对肿瘤细胞凋亡水平的影响

目的:采用小鼠腋下接种瘤株的方法,建立肝癌荷瘤小鼠动物模型;利用血清药理学的方法,观察环磷酰胺(CTX)舍药血清体外的抑制肿瘤细胞生长及调亡作用的研究.方法 :小鼠肝癌细胞混悬液用生理盐水按1:1进行稀释制成含瘤腹水混悬液,在给药前24 h,每只小鼠腋窝皮下接种0.2 ml.CTX对小鼠肝癌抑瘤实验连续给药10 d,测定肿瘤作用端粒酶活性与细胞凋亡表达.结果:(1)CTX能够明显抑制肝癌肿瘤的生长(P＜0.01);(2)30%、20%和10%含药血清高中低剂量含药血清对HepG2肿瘤细胞具有明显的抑瘤作用,Hochest染色肿瘤细胞出现凋亡形态;而流式细胞仪检测可见含药血清高中低剂量的促肿瘤凋亡率,明显高于正常血清组.CTX能够明显升高肝癌荷瘤小鼠体内bc1-2的水平(P＜0.01);(3)CTX能够明显促进肝癌细胞的凋亡.结论 :CTX具有抑制小鼠肝癌的作用;能够明显促进肝癌细胞的凋亡;CTX的抑瘤作用可能与升高动物体内的bcl-2水平及促进癌细胞的凋亡有关,从而表现抗肿瘤的作用.     

结肠腺癌中结肠癌干细胞的分离、鉴定

目的从人结肠腺癌组织中分离、鉴定结肠癌干细胞,并初步观察其生物学特性。方法利用新鲜结肠腺癌组织,无血清悬浮成球培养,流式细胞检测ESA、CD44表达情况,体外观察其诱导分化及CK20、Muc表达情况,Balb／C小鼠移植观察其成瘤情况。结果从人原代结肠腺癌中分离、纯化EpCAM^high CD44^＋结肠癌干细胞,结肠癌原代细胞中EpCAM^highCD44^＋细胞比例为1．7％～38％（平均5．4％）。单克隆形成实验证实结肠癌组织中存在肿瘤干细胞。其比例为（2．07±0．11）％,分离获得的EpCAM^highCD44^＋细胞能在无血清培养基中“成球”,在血清诱导下能贴壁分化;将EpCAM^highCD44^＋细胞移植在Balb／C裸鼠体内,表现出很强的致瘤性,移植瘤中EpCAM^highCD44^＋细胞比例为3．6％～43．2％（平均15．2％）,所有的移植瘤经组织学测定,均形成腺管样结构,表达结肠特异性分化标志物CK-20、中性上皮粘蛋白（neutral epithelial mucins,Muc）。结论人结肠腺癌组织中存在EpCAM^highCD44^＋细胞群,具有和普通干细胞相类似的无限增殖、自我更新和分化能力。     

microRNA-451对人结肠癌细胞SW620裸鼠皮下种植瘤生长的抑制作用及机制探讨

目的 探讨microRNA-451(miR-451)对人结肠癌细胞系SW620裸鼠皮下种植瘤生长的影响,并探讨其可能机制.方法 18只裸鼠随机分为3组,实验组(SW-620-451组)、阴性对照组(SW-620-NC)、空白对照组(SW-620组),每组6只,分别皮下接种转染miRNA-451 agomir的SW620细胞、转染了阴性片段agomir Negative Control(NC)的SW620细胞和不经处理的结肠癌SW620细胞,并每周两次于瘤体内分别注射miRNA-451 agomir、miRNA-451 agomir NC片段及生理盐水.比较各组裸鼠皮下形成瘤体的大小并计算抑瘤率,接种四周后处死裸鼠取组织,用免疫组化法和Western-blot法定性定量分析和比较肿瘤相关基因c-myc的表达.结果 各组裸鼠皮下接种肿瘤细胞6天后均有瘤体形成,成瘤率100％,实验组(SW-620-451组)瘤体生长速度明显低于其他两组(p＜0.05);时间终点为第30天时,实验组(SW-620-451组)裸鼠皮下种植瘤的体积为(0.95±0.13)cm3,阴性对照组(SW-620-NC组)为(2.25±0.50) cm3,空白对照组(SW-620组)为(2.46±0.59)cm3;实验组(SW-620-451组)瘤体体积显著小于其他两组体积(p＜0.05);实验组(SW-620-451组)瘤体质量为(1.15±0.13)g,明显低于SW-620-NC组(2.59±0.46)g及SW-620组(2.76±0.44)g(p ＜0.05).实验组种植瘤中c-myc的表达量较另外两组下降(p＜0.05).结论 转染miR-451后可以抑制结肠癌细胞SW620裸鼠皮下移植瘤的生长,其机制可能与下调c-myc表达有关.     

RNA干扰CD133基因对结肠癌干细胞生物学行为的影响

目的探讨CD133基因表达、活化被阻断后对结肠癌干细胞生物学行为的影响。方法从EpcAMhighCD44＋结肠癌干细胞中流式分选获得CD133＋细胞,感染LV-CD133shRNA载体慢病毒后观察CD133＋结肠癌干细胞在生长方式、成球能力、克隆形成率、成瘤能力以及ABCC2mRNA的变化;Westernblot分析CD133-细胞中CD133蛋白表达情况。结果EpcAMhighCD44＋结肠癌干细胞中CD133＋细胞比例为89．2％。实验组经过LV-CD133shRNA载体病毒感染后,在干细胞养液中细胞改悬浮生长的方式为贴壁生长,不能形成细胞球。MTT法测定发现细胞增殖减慢,克隆形成率明显下降。将感染细胞移植在Balb／C裸鼠体内,在观察期间,感染LV—CD133shRNA载体病毒的CD133＋细胞无肿瘤形成。ABCG2mRNA表达水平明显降低（P〈0．01）。从EpcAMhighCD44＋结肠癌干细胞中流式分选获得CD133-细胞,其中也有CD133蛋白的表达。结论CD133维持结肠癌干细胞生物学特性。     

力学-电沉积法制备纳米晶光亮镍

提出一种力学-电沉积技术,在未添加任何光亮剂和晶粒细化添加剂的情况下制备出表面平整光亮的纳米晶镍沉积层。与传统电沉积技术的对照实验表明,硬质粒子在镍的沉积过程中不停磨擦和扰动阴极表面及附近溶液,能有效阻止氢气泡和杂质的吸附,避免凹坑、麻点和积瘤等表面缺陷产生。通过SEM,XRD和TEM观察和性能测试发现,硬质粒子的磨擦作用能改变沉积层的组织结构,进而影响其性能。与传统技术所制备的沉积层相比,用本文所述技术在相同条件下所制备镍沉积层的晶粒显著细化,尺寸大约30-80nm;各晶面的衍射强度和（200）面的择优取向度明显减小,（111）面和（220）面择优取向度增加;显微硬度显著提高;磁性能明显改变,饱和磁化强度减小,矫顽力增大。用力学-电沉积技术所制备镍沉积层的微观结构和性能受阴极转速和电流密度的影响。     

不同剂量高强度聚焦超声辐照与HIFU消融VX2兔肝移植瘤量效关系的实验研究

目的探讨不同剂量高强度聚焦超声辐照与消融的量效关系。方法兔肝VX2肿瘤模型按功率不同予以首次辐照,24h后各组再予180W在相同参数下行单条直线扫描。分别于首次、再次辐照后观察靶区的变化,测量再次辐照后消融区域的长、宽、高,计算体积及相应的能效因子（EEF）。结果备纽靶组织均于单条线扫后出现消融,消融纽织的形态随首次辐照功率的增加而不规则;消融后的EEF和首次预辐照功率存在负相关关系（r=-0．941,P〈0．01）。结论研究HIFU预辐照剂量和消融效率间的关系能为HIFU治疗提供新思路和剂量参考。     

齐墩果酸抑制肝癌细胞QGY增殖和诱导凋亡的作用研究

目的研究齐墩果酸对人肝癌细胞QGY增殖的作用及与细胞内钙离子浓度（[Ca2＋]i）关系。方法将浓度分别为40、80、100μg／ml齐墩果酸作用肝癌H细胞QGY24h后,DAPI染色,以荧光显微镜观察细胞形态变化;以11组不同浓度齐墩果酸（5—400μg／ml）作用QGY细胞24h后,用四甲基偶氮唑蓝（Myr）法检测QGY增殖情况;分别以不同浓度齐墩果酸（80、100、120μg／ml）作用QGY细胞24h后,流式细胞仪检测细胞周期改变、细胞凋亡率和[Ca2＋]i。结果细胞增殖被抑制并发生凋亡：不同浓度齐墩果酸能够抑制QGY细胞株增殖,且在5—120μg／mL范围内呈剂量依赖性,药物作用细胞24h、48的Ic50分别为76．27μg／mL和66．56μg／mL;处理组细胞周期在s期产生阻滞、细胞内[Ca2＋]i较对照组显著增加,细胞凋亡率和[Ca2＋]i与药物浓度存依赖关系。结论齐墩果酸能够抑制肝癌细胞QGY增殖和诱导其凋亡;诱导凋亡可能与细胞内[Ca2＋]i增加有关。     

解聚复肾宁对糖尿病肾病大鼠TNF—OL、MCP-1的影响

目的观察解聚复肾宁（Jiejufushenning,JJFSN）对糖尿病（Diabetes mellitus,DM）大鼠肾组织肿瘤坏死因子-α（Tumorneerosisfactor-alpha,TNF-α）、单核细胞趋化蛋白-1（Monocyte chemoattractant protein-1,MCP-1）和血清TNF-α的影响,探讨其肾保护作用机制。方法腹腔注射链脲佐菌素（Streptozotocin,STZ）建立SD大鼠DM模型,将成模DM大鼠随机分为3组：DM模型组（B组）、JJFSN组（C组）、厄贝沙坦（Irbesartan）组（D组）,另设正常对照组（A组）。采用相应干预措施处理12周。常规方法测定12周末各组大鼠空腹血糖（FBG）、血尿素氮（BUN）、血肌酐（Scr）、肾重／体重（KW／BW）、24h尿蛋白（24huFro）;放免法测血清TNF-α含量：免疫组织化学方法测肾组织TNF—Ot、MCP-1的表达;PAS染色评估细胞外基质;电镜观察肾组织超微结构改变。结果与A组相比．B组大鼠FBG、BUN、Scr、KW／BW、24huPro及血清TNF-α升高（P〈0．05）,肾组织TNF—Ot、MCP-1表达明显增高（P〈0．05）;肾组织超微结构明显异常;C组和D组上述指标显著改善（P〈0．05）,肾组织超微结构异常改善。结论竹FSN能延缓DM大鼠肾损害进程,其机制可能与抑制TNF-α、MCP-1上调有关。     

Blockage of the NLRP3 inflammasome by MCC950 improves anti-tumor immune responses in head and neck squamous cell carcinoma

The NLRP3 inflammasome is a critical innate immune pathway responsible for producing active interleukin (IL)-1β, which is associated with tumor development and immunity. However, the mechanisms regulating the inflammatory microenvironment, tumorigenesis and tumor immunity are unclear. Herein, we show that the NLRP3 inflammasome was over-expressed in human HNSCC tissues and that the IL-1β concentration was increased in the peripheral blood of HNSCC patients. Additionally, elevated NLRP3 inflammasome levels were detected in tumor tissues of Tgfbr1/Pten 2cKO HNSCC mice, and elevated IL-1β levels were detected in the peripheral blood serum, spleen, draining lymph nodes and tumor tissues. Blocking NLRP3 inflammasome activation using MCC950 remarkably reduced IL-1β production in an HNSCC mouse model and reduced the numbers of myeloid-derived suppressor cells (MDSCs), regulatory T cells (Tregs) and tumor-associated macrophages (TAMs). Moreover, inhibiting NLRP3 inflammasome activation increased the numbers of CD4⁺ and CD8⁺ T cells in HNSCC mice. Notably, the numbers of exhausted PD-1⁺ and Tim3⁺ T cells were significantly reduced. A human HNSCC tissue microarray showed that NLRP3 inflammasome expression was correlated with the expression of CD8 and CD4, the Treg marker Foxp3, the MDSC markers CD11b and CD33, and the TAM markers CD68 and CD163, PD-1 and Tim3. Overall, our results demonstrate that the NLRP3 inflammasome/IL-1β pathway promotes tumorigenesis in HNSCC and inactivation of this pathway delays tumor growth, accompanied by decreased immunosuppressive cell accumulation and an increased number of effector T cells. Thus, inhibition of the tumor microenvironment through the NLRP3 inflammasome/IL-1β pathway may provide a novel approach for HNSCC therapy.     

Targeted inhibition of Livin resensitizes renal cancer cells towards apoptosis

Cancer cells are typically characterized by apoptosis deficiency. In order to investigate a possible role for the anti-apoptotic livin gene in renal cell cancer (RCC), we analyzed its expression in tumor tissue samples and in RCC-derived cell lines. In addition, we studied the contribution of livin to the apoptotic resistance of RCC cells by RNA interference (RNAi). Livin gene expression was detected in a significant portion of RCC tumor tissue specimens (13/14, 92.9%) and tumor-derived cell lines (12/15, 80.0%). Moreover, targeted inhibition of livin by RNAi markedly sensitized RCC cells towards proapoptotic stimuli, such as UV irradiation or the chemotherapeutic drugs etoposide, 5-fluorouracil, and vinblastine. These effects were specific for livin expressing tumor cells. We conclude that livin can contribute significantly to the apoptosis resistance of RCC cells. Targeted inhibition of livin could represent a novel therapeutic strategy to increase the sensitivity of renal cancers towards pro-apoptotic agents. Received 30 November 2006; received after revision 22 February 2007; accepted 20 March 2007     

Evidence for a role of IFN gamma in control of Listeria monocytogenes in T cell deficient mice.

The role of interferon (IFN) gamma in controlling chronic infections of Listeria monocytogenes (Listeria) was studied in athymic C57BL/6 nu/nu mice, and by treating thymectomized C57BL/6 +/+ mice with monoclonal rat CD4 and CD8-specific monoclonal antibodies (Mab). Mice treated with a combination of the two T cell subset antibodies were similar to athymic, nude mice in being able to control Listeria infection, keeping the titers below 3-5 log10 bacteria per organ, but they could not eliminate them completely. Treatment with antibodies to IFN gamma of nude or CD4+ + CD8+ - T cell-depleted mice suffering from chronic Listeria infection caused a marked increase of Listeria titers in liver and spleen. This result implies a role of IFN gamma in maintaining anti-Listeria resistance in mice lacking mature T cells.     

Effects of probenecid on plasma/tissue distribution of14C-benzylpenicillin in rats

Summary Probenecid (50 mg·kg^–1) was found to induce an increase of the plasma concentration of¹⁴C-benzylpenicillin with a decrease of the concentration in liver and kidney. Accumulation in corresponding tissue slices was reduced by probenecid. Therefore, the well known increase of penicillin in plasma after probenecid seems to be not only due to an inhibition of renal excretion but also to a reduced tissue uptake in liver and kidney.     

Pseudocholinesterase in obesity: Hypercaloric diet induced changes in experimental obese mice

Summary Pseudocholinesterase activity is significantly higher in liver and serum, but lower in adipose tissue of genetically obese, diabetic and gold thioglucose treated mice. Similar enzyme changes were also observed in lean mice on a high carbohydrate diet. A marked reduction (40%) in PChE activity occurred in the liver of genetically diabetic mice when starved for 24 h. These observations suggest that pseudocholinesterase induction in the liver and repression in the adipose tissue is affected by excessive calorie intake in obesity. This provides a model to study the biological function of PChE in health and disease.Acknowledgments. We thank Dr Charles A. Janeway Child Health Centre and Faculty of Medicine, Memorial University of Newfoundland for financial support.